Mirum Pharmaceuticals, Inc.
DE ˙ DB ˙ US6047491013
76,16 € ↓ -0,96 (-1,24%)
2026-06-04
AKTIENPREIS
SecurityDE:08D / Mirum Pharmaceuticals, Inc.
InstitutionStrs Ohio
Latest Disclosed Ownership12,700 shares
Latest Disclosed Value $ 1,173,226
Strs Ohio reports 29.59% increase in ownership of 08D / Mirum Pharmaceuticals, Inc.

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 12,700 shares of Mirum Pharmaceuticals, Inc. (DE:08D) valued at $952,500 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 9,800 shares of Mirum Pharmaceuticals, Inc.. This represents a change in shares of 29.59% during the quarter. The current value of the position is $967,232 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F MIRUM PHARMACEUTICALS COM_STK 604749101 12,700 2,900 29.59 1,173 51.55 0.0047
2026-02-02 2025-12-31 13F MIRUM PHARMACEUTICALS COM_STK 604749101 9,800 -2,900 -22.83 774 -16.86 0.0029
2025-10-30 2025-09-30 13F MIRUM PHARMACEUTICALS COM_STK 604749101 12,700 9,000 243.24 931 395.21 0.0034
2025-08-04 2025-06-30 13F MIRUM PHARMACEUTICALS COM_STK 604749101 3,700 -8,500 -69.67 188 -65.76 0.0007
2025-05-28 2025-03-31 13F MIRUM PHARMACEUTICALS COM_STK 604749101 12,200 6,000 96.77 550 114.45 0.0023
2025-05-28 2024-12-31 13F MIRUM PHARMACEUTICALS COM_STK 604749101 6,200 6,200 256 0.0010
2023-01-26 2022-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 0 -10,200 -100.00 0 -100.00
2022-10-27 2022-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 10,200 0 0.00 214 8.08 0.0010
2022-07-25 2022-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 10,200 600 6.25 198 -6.16 0.0009
2022-04-21 2022-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 9,600 0 0.00 211 37.91 0.0008
2022-01-24 2021-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 9,600 0 0.00 153 -19.90 0.0005
2021-10-22 2021-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 9,600 -4,000 -29.41 191 -18.72 0.0007
2021-07-26 2021-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 13,600 1,300 10.57 235 -3.29 0.0008
2021-04-23 2021-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 12,300 0 0.00 243 13.55 0.0009
2021-01-25 2020-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 12,300 0 0.00 214 -9.70 0.0008
2020-12-14 2020-09-30 13F MIRUM PHARMACEUTICALS COM 604749101 12,300 11,600 1,657.14 237 1,723.08 0.0010
2020-07-23 2020-06-30 13F MIRUM PHARMACEUTICALS COM 604749101 700 0 0.00 13 44.44 0.0001
2020-04-23 2020-03-31 13F MIRUM PHARMACEUTICALS COM 604749101 700 0 0.00 9 -47.06 0.0000
2020-01-24 2019-12-31 13F MIRUM PHARMACEUTICALS COM 604749101 700 700 17 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.